Skip to content

Evaluation of the Value of Cerebral Perfusion Scintigraphy in the Study of Post-stroke Fatigability

Evaluation of the Value of Cerebral Perfusion Scintigraphy in the Study of Post-stroke Fatigability

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03543280
Enrollment
32
Registered
2018-06-01
Start date
2018-02-23
Completion date
2019-02-28
Last updated
2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigability Post Stroke

Keywords

fatigability post stroke, post stroke, high-speed CT, MRI

Brief summary

At present there is no consensus for post-stroke imaging except for the realization of early cerebral CT at 24 hours post-thrombolysis. The use of cerebral perfusion scintigraphy would predict the course of a stroke. Indeed, it has been shown that a good perfusion is linked to a good evolution of the neurological deficit. This test is used routinely to evaluate cerebral perfusion in patients with stroke. This technique was also used to study the mechanisms of post-stroke aphasia and to highlight neuronal disconnections after stroke, a reflection of the functioning of neural networks. Neuropsychological tests are almost always done at 3 months. Fatigue is studied: PSF scale at 3 months, 6 months and 2 years. Research needs to be continued in this area because the pathophysiology remains unknown and the symptoms are disabling for patients. Using cerebral perfusion imaging would bring elements of understanding of this mechanism and ultimately improve the management of patients.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

* Patients: 18 to 60 years old at the initial diagnosis * Admission for transient ischemic attack, stroke, dissection, TVC * RANKIN less than or equal to 2 * Neuropsychological tests at +3 months: MoCA\> 26 (to eliminate cognitive deteriorations too important for the good realization of the battery) * Absence of psychiatric history * Absence of psychotropic medication * No history of stroke * No complaint of pre-stroke fatigue * Having signed the consent form

Exclusion criteria

* Impossibility of giving the subject or his family enlightened information (subject in emergency situation, difficulties in understanding the subject, etc.) * Subject under the protection of justice * Subject under guardianship or curatorship * Refusal of the patient to participate in the study

Design outcomes

Primary

MeasureTime frame
Evaluate fatigue symptoms in stroke patientsAfter the period following a stroke: 1 month

Countries

France

Contacts

Primary ContactIzzie Jacques NAMER, MD, PhD
Izzie.Jacques.NAMER@chru-strasbourg.fr33 3 88 12 75 50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026